Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 20, 2020 - Issue 6
Submit an article Journal homepage
1,561
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Immunotherapy for urothelial cancer: from the diagnostic pathologist’s point of view

Alessia CimadamoreSection of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, ItalyView further author information
,
Marina ScarpelliSection of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, ItalyView further author information
,
Francesco MassariDivision of Oncology, S.Orsola-Malpighi Hospital, Bologna, ItalyView further author information
,
Markus EcksteinInstitute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität, Erlangen-Nürnberg, Erlangen, GermanyView further author information
,
Thomas GevaertDepartment of Urology, UZ Leuven, Leuven, Belgium;Organ Systems, KU Leuven, Leuven, Belgium;Department of Pathology, AZ Klina, Brasschaat, BelgiumView further author information
,
Liang ChengDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USAView further author information
,
Antonio Lopez-BeltranDepartment of Pathology and Surgery, Cordoba University, Faculty of Medicine, Cordoba, SpainView further author information
&
Rodolfo MontironiSection of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 539-544 | Received 30 Sep 2019, Accepted 20 Feb 2020, Published online: 25 Feb 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Andreia Bilé-Silva, Antonio Lopez-Beltran, Ana Blanca, Fernando Lopez-Rios, Enrique Gómez-Gómez, Alessia Cimadamore, Rodolfo Montironi, Nuno Vau & Liang Cheng. (2023) Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward. Expert Opinion on Biological Therapy 23:5, pages 407-418.
Read now

Articles from other publishers (5)

Antonio López-Beltrán, Pilar González-Peramato, Julián Sanz-Ortega, Juan Daniel Prieto Cuadra, Isabel Trias, Rafael J. Luque Barona, María Eugenia Semidey, Pablo Maroto & Ferran Algaba. (2023) Aspectos prácticos sobre la determinación de PD-L1 en el tratamiento de carcinoma urotelial. Consenso del grupo de uropatología de la SEAP. Revista Española de Patología 56:4, pages 261-270.
Crossref
Maria Teresa Dawid de Vera, Juan Daniel Prieto Cuadra, Martina Álvarez Pérez, Alicia Garrido-Aranda, Emilio Alba Conejo & Isabel Hierro Martín. (2023) PD-L1 immunoexpression and molecular characterization of histological subtypes in urothelial carcinoma. Revista Española de Patología 56:1, pages 10-20.
Crossref
Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari, Ilaria Girolami, Fabio Pagni & Albino Eccher. (2022) Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems. Journal of Personalized Medicine 12:7, pages 1073.
Crossref
Andrada Loghin, Adela Nechifor-Boilă, Angela Borda, Ioan Alin Nechifor-Boilă, Septimiu Voidazan & Myriam Decaussin-Petrucci. (2021) Programmed death ligand-1 (PD-L1) immunohistochemical assessment using the QR1 clone in muscle-invasive urothelial carcinomas: a comparison with reference clones 22C3 and SP263. Virchows Archiv 480:2, pages 303-313.
Crossref
Antonio Lopez-Beltran & Liang Cheng. (2021) Stage T1 bladder cancer: diagnostic criteria and pitfalls. Pathology 53:1, pages 67-85.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.